Hextar Healthcare Bhd(MY:7803)
RM0.06+0.00 (+9.09%)
MY:7803
Hextar Healthcare Bhd financials statements
RM0.06
At close:+0.00 (+9.09%)
Hextar Healthcare Bhd (7803) Ratios
Hextar Healthcare Bhd Ratios
MY:7803's free cash flow for Q2 2026 was RM-4.24M. For the 2026 fiscal year, MY:7803's free cash flow was decreased by RM-669.00K and operating cash flow was RM-3.58M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.68 | 5.65 | 6.02 | 3.81 | 9.60 |
| Quick Ratio | 3.81 | 3.31 | 4.15 | 2.69 | 7.16 |
| Cash Ratio | 1.01 | 0.34 | 0.85 | 1.28 | 6.53 |
| Solvency Ratio | -1.65 | 0.11 | -1.24 | -0.46 | 3.11 |
| Operating Cash Flow Ratio | 0.78 | -1.19 | -0.73 | -0.28 | 2.94 |
| Short-Term Operating Cash Flow Coverage | 308.27 | -82.66 | -244.75 | -57.05 | 5820.11 |
| Net Current Asset Value | RM 107.07M | RM 123.18M | RM 148.61M | RM 189.91M | RM 374.64M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.06 | 1.06 | 1.07 | 1.14 | 1.11 |
| Debt Service Coverage Ratio | -111.82 | 6.80 | -48.25 | -73.04 | 1584.92 |
| Interest Coverage Ratio | -98.57 | -31.10 | -88.81 | -228.78 | 2255.97 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Net Debt to EBITDA | 0.53 | -4.62 | 0.38 | 1.82 | -1.19 |
| Profitability Margins | |||||
| Gross Profit Margin | -5.60% | -7.45% | -26.66% | 77.32% | 41.89% |
| EBIT Margin | -25.08% | -10.96% | -47.26% | -35.18% | 46.03% |
| EBITDA Margin | -25.08% | 0.81% | -34.49% | -26.69% | 48.61% |
| Operating Profit Margin | -22.56% | -11.14% | -47.20% | -25.02% | 44.96% |
| Pretax Profit Margin | -25.30% | -11.32% | -47.52% | -35.29% | 46.01% |
| Net Profit Margin | -30.35% | -9.47% | -41.60% | -31.10% | 36.09% |
| Continuous Operations Profit Margin | -30.35% | -7.88% | -41.54% | -31.10% | 36.09% |
| Net Income Per EBT | 119.95% | 83.66% | 87.53% | 88.14% | 78.44% |
| EBT Per EBIT | 112.16% | 101.63% | 100.68% | 141.05% | 102.34% |
| Return on Assets (ROA) | -9.38% | -2.59% | -11.13% | -8.05% | 27.93% |
| Return on Equity (ROE) | -9.95% | -2.74% | -11.87% | -9.21% | 30.90% |
| Return on Capital Employed (ROCE) | -7.33% | -3.21% | -13.34% | -7.23% | 37.36% |
| Return on Invested Capital (ROIC) | -7.29% | -2.23% | -11.61% | -6.34% | 29.26% |
| Return on Tangible Assets | -9.47% | -2.67% | -11.45% | -8.24% | 28.64% |
| Earnings Yield | -42.94% | -7.40% | -22.16% | -16.82% | 41.93% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.24 | 2.68 | 4.32 | 5.05 | 18.75 |
| Payables Turnover | 18.58 | 15.33 | 20.93 | 5.46 | 28.58 |
| Inventory Turnover | 3.53 | 2.47 | 3.42 | 0.49 | 2.69 |
| Fixed Asset Turnover | 0.86 | 0.83 | 0.81 | 0.84 | 2.45 |
| Asset Turnover | 0.31 | 0.27 | 0.27 | 0.26 | 0.77 |
| Working Capital Turnover Ratio | 1.25 | 1.05 | 0.86 | 0.60 | 1.74 |
| Cash Conversion Cycle | 246.78 | 259.84 | 173.70 | 743.83 | 142.59 |
| Days of Sales Outstanding | 162.91 | 136.03 | 84.45 | 72.29 | 19.46 |
| Days of Inventory Outstanding | 103.52 | 147.62 | 106.69 | 738.41 | 135.89 |
| Days of Payables Outstanding | 19.65 | 23.81 | 17.44 | 66.88 | 12.77 |
| Operating Cycle | 266.43 | 283.65 | 191.14 | 810.70 | 155.36 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | -0.03 | -0.02 | -0.02 | 0.16 |
| Free Cash Flow Per Share | 0.01 | -0.03 | -0.03 | -0.04 | 0.12 |
| Dividend Paid and CapEx Coverage Ratio | 2.79 | -12.07 | -4.15 | -1.39 | 3.81 |
| Capital Expenditure Coverage Ratio | 2.79 | -12.07 | -4.15 | -1.39 | 3.81 |
| Operating Cash Flow Coverage Ratio | 4.37 | -8.70 | -3.98 | -3.59 | 72.02 |
| Operating Cash Flow to Sales Ratio | 0.12 | -0.22 | -0.14 | -0.11 | 0.26 |
| Free Cash Flow Yield | 11.34% | -18.67% | -9.58% | -10.56% | 22.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.33 | -13.53 | -4.51 | -5.95 | 2.36 |
| Price-to-Sales (P/S) Ratio | 0.71 | 1.28 | 1.88 | 1.85 | 0.86 |
| Price-to-Book (P/B) Ratio | 0.23 | 0.37 | 0.54 | 0.55 | 0.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.82 | -5.36 | -10.44 | -9.47 | 4.47 |
| Price-to-Operating Cash Flow Ratio | 5.66 | -5.80 | -12.96 | -16.31 | 3.30 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.17 | -1.34 | 0.05 | 0.06 |
| Enterprise Value Multiple | -2.29 | 153.78 | -5.06 | -5.11 | 0.59 |
| Enterprise Value | 85.06M | 182.57M | 270.14M | 244.02M | 146.40M |
| EV to EBITDA | -2.29 | 153.78 | -5.06 | -5.11 | 0.59 |
| EV to Sales | 0.57 | 1.24 | 1.75 | 1.36 | 0.28 |
| EV to Free Cash Flow | 7.16 | -5.20 | -9.71 | -6.98 | 1.48 |
| EV to Operating Cash Flow | 4.60 | -5.63 | -12.05 | -12.02 | 1.09 |
| Tangible Book Value Per Share | 0.41 | 0.47 | 0.53 | 0.66 | 0.69 |
| Shareholders’ Equity Per Share | 0.41 | 0.49 | 0.54 | 0.68 | 0.71 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.20 | 0.30 | 0.13 | 0.12 | 0.22 |
| Revenue Per Share | 0.13 | 0.14 | 0.15 | 0.20 | 0.60 |
| Net Income Per Share | -0.04 | -0.01 | -0.06 | -0.06 | 0.22 |
| Tax Burden | 1.20 | 0.84 | 0.88 | 0.88 | 0.78 |
| Interest Burden | 1.01 | 1.03 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.28 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.49 | 1.71 | 0.35 | 0.36 | 0.72 |
Currency in MYR
